Breast Cancer: Our Clinical Trials

You may be offered the opportunity to take part in a clinical trial at some point during your treatment. Clinical trials are research studies that evaluate the safety and effectiveness of new treatment approaches for diseases. In some cases, a study may give you access to new therapies that are not yet readily available. Clinical trials may also be used to compare diagnostic tests, prevention strategies, or other aspects of care for cancer patients. Learn more about clinical trials.

Below is a listing of breast cancer clinical trials that are currently enrolling patients at Memorial Sloan-Kettering Cancer Center.

Showing 1 - 50 of 57 trials
Title Investigator
A Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants
[Protocol 06-024]
Disa, Joseph, MD
A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma
[Protocol 12-249]
Goldfarb, Shari, MD
A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049]
Dickler, Maura, MD
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233]
Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of BYL719 with Letrozole or Exemestane for Treating Locally Advanced Inoperable or Metastatic Breast Cancer
[Protocol 13-027]
Dickler, Maura, MD
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131]
Voss, Martin, MD
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155]
Traina, Tiffany, MD
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169]
Rusch, Valerie, MD
A Phase I Study of HER2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer
[Protocol 04-101]
Gilewski, Teresa, MD
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205]
Lacouture, Mario, MD
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046]
Seidman, Andrew, MD
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer
[Protocol 08-122]
Fornier, Monica, MD
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Patients with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005]
Chandarlapaty, Sarat, MD, PhD
A Phase I/II Study of Intrathecal Trastuzumab in Women with HER2-Positive Breast Cancer that Spread to the Spinal Fluid
[Protocol 12-123]
Pentsova, Elena, MD
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors
[Protocol 11-117]
Gounder, Mrinal, MD
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140]
Traina, Tiffany, MD
A Phase II Study of Cabozantinib in Women with Hormone Receptor-Positive Breast Cancer that Spread to the Bone
[Protocol 12-091]
Fornier, Monica, MD
A Phase II Study of Docosahexaenoic Acid (DHA) in Survivors of Triple-Negative Breast Cancer
[Protocol 12-267]
Hudis, Clifford, MD
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190]
Traina, Tiffany, MD
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029]
Dickler, Maura, MD
A Phase II Study of Paclitaxel plus Tivozanib or Placebo in Women with Persistent or Recurrent Triple-Negative Breast Cancer
[Protocol 13-047]
Dickler, Maura, MD
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142]
Dang, Chau, MD
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer
[Protocol 10-114]
Powell, Simon, MD
A Phase II Study of SNX-5422 in Patients with Select Advanced HER2 Cancers
[Protocol 13-112]
Voss, Martin, MD
A Phase II Study of Veliparib plus Temozolomide, Veliparib plus Carboplatin and Paclitaxel, or Carboplatin and Paclitaxel with Placebo in Patients with BRCA Mutations and Metastatic Breast Cancer
[Protocol 12-122]
Robson, Mark, MD
A Phase III Study Comparing Mometasone Furoate with Eucerin to Treat Radiation-Related Skin Redness and Peeling in Breast Cancer Patients after Mastectomy
[Protocol 13-069]
Olm-Shipman, Molly, RN
A Phase III Study of Accelerated Whole Breast Radiation Therapy with a Boost versus Standard Whole Breast Radiation with a Boost in Women with Early-Stage Breast Cancer (RTOG 1005)
[Protocol 12-158]
Parhar, Preeti, MD
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290]
Dickler, Maura, MD
A Phase III Study of Chemotherapy and Trastuzumab with or without Pertuzumab in Patients with Operable HER2-Positive Breast Cancer
[Protocol 12-115]
Dang, Chau, MD
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118]
Lake, Diana, MD
A Phase III Study of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
[Protocol 11-190]
King, Tari, MD
A Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
[Protocol 09-116]
Roth, Andrew, MD
A Pilot Study of Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Requiring Treatment of the Internal Mammary Lymph Nodes
[Protocol 10-025]
Ho, Alice, MD
A Pilot Study of Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer Scheduled for Mastectomy
[Protocol 11-202]
McArthur, Heather, MD
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
[Protocol 11-194]
Ginex, Pamela, RN, EDD
A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy
[Protocol 07-130]
Ahles, Tim, PhD
A Study Assessing the Feasibility of Treatment with Paclitaxel, Trastuzumab, and Lapatinib in Women with HER2-Positive Early-Stage Breast Cancer
[Protocol 13-002]
Dang, Chau, MD
A Study Assessing Varenicline (Chantix) to Treat Tobacco Dependence in Breast Cancer Patients Scheduled for Mastectomy and Reconstructive Surgery
[Protocol 11-136]
Ostroff, Jamie, PhD
A Study of Non-Hormonal Vaginal Moisturizer in Hormone Receptor-Positive Postmenopausal Cancer Survivors
[Protocol 12-232]
Carter, Jeanne, PhD
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie, PhD
An Interactive e-Health Program to Promote Health Behaviors Among Cancer Survivors
[Protocol 12-090]
Ostroff, Jamie, PhD
Assessment of a Customized Computer Program for Reducing Fears of Breast Cancer Recurrence
[Protocol 11-204]
Lichtenthal, Wendy, PhD
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
[Protocol 12-089]
Tew, William, MD
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051]
Offit, Kenneth, MD
Developing Culturally Tailored Support Groups for Chinese Immigrants with Breast Cancer: A Pilot Study
[Protocol 12-105]
Leng, Jennifer, MD, MPH
Development of Group Interventions for Breast Cancer Survivors
[Protocol 12-291]
Lichtenthal, Wendy, PhD
EMPOWER Study: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
[Protocol 10-104]
Oeffinger, Kevin, MD
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
[Protocol 10-071]
Blinder, Victoria, MD
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068]
Stadler, Zsofia, MD
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast
[Protocol 13-023]
Van Zee, Kimberly, MD